Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Keratosis, Actinic 1Carcinoma, Basal Cell 1

Interventions

Aminolevulinic Acid 113-ingenyl angelate 9Photochemotherapy 5Imiquimod 5Fluorouracil 4Petrolatum 3Solutions 2SR-T100 2Gels 2Cryotherapy 2potassium dobesilate 1perillyl alcohol 1endonuclease V, phage T4 1dehydroftorafur 1calcipotriene 1afamelanotide 1Triamcinolone 1Therapies, Investigational 1Papillomavirus Vaccines 1Ointments 1Melatonin 1Lasers 1LEO 43204 1Isotretinoin 1Imipramine 1Excipients 1Eflornithine 1Deoxyribonuclease (Pyrimidine Dimer) 1Cholecalciferol 1Chemexfoliation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Keratosis, Actinic × endonuclease V, phage T4 × Clear all
NCT00089180 2015-12-04

T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

National Cancer Institute (NCI)

Phase 2 Completed
100 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡